The Week Ahead In Biotech: PDUFA Dates, IPOs And More

Biotech stocks witnessed a slowdown in momentum last week, which was a relatively slow one in terms of news flow. Amgen, Inc. read more.....»»

The ASCO conference closed Tuesday, although presentations at the conference triggered some huge stocks moves. read more.....»»

Below is a list of notable corporate events for the week beginning June 25. Note, this list is not comprehensive and all dates are subject to change. All times are ET. Monday Notable Earnings Latest Rati.....»»

A bit of a lull took place in the biotech space ahead of earnings season; IPO activity was non-existent, but there was some action on account of clinical trial results. Here's a look at the upcoming week's catalytic events. read more.....»»

A bit of a lull took place in the biotech space ahead of earnings season; IPO activity was non-existent, but there was some action on account of clinical trial results. He.....»»

Below is a list of notable corporate events for the week beginning July 23. Note, this list is not comprehensive and all dates are subject to change. All times are ET. Monday Economic USA Existing Home Sales for Jun 5.38M vs 5.46M Est; Prio.....»»

Below is a list of notable corporate events for the week beginning July 23. Note, this list is not comprehensive and all dates are subject to change. All times are ET. MondayEconomic Latest Ratin.....»»

After recording stellar gains of 4.3 percent in the week ended Aug. 31 to close the month .....»»

After recording stellar gains of 4.3 percent in the week ended Aug. 31 to close the month in the green, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) saw a moderation in momentum in the holiday-shortened week ending Sept. 7. read more.....»»

Below is a list of notable corporate events for the week beginning Sept. 24. Note, this list is not comprehensive and all dates are subject to change. All times are ET. MondayConferences read more.....»»

As we step into the final quarter of 2018, biotech stocks have recorded double-digit gains for the year-to-date period. Will the run up continue? Stay tuned to the following events of the upcoming week. read more.....»»

The earnings season hasn't panned out well for pharma companies, with Amgen, Inc. (NASDAQ: AMGN), Novartis AG (NYS.....»»

The earnings season hasn't panned out well for pharma companies, with Amgen, Inc. (NASDAQ: AMGN), Novartis AG (NYSE: NVS) and Illumina, Inc. read more.....»»

Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts. read more.....»»

Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the weakness may be traced back to the across-t.....»»

Biotech stocks had a volatile ride in the week .....»»

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came under pressure following the U.S. read more.....»»

Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. read more.....»»

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. read more.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) read more.....»»